A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation

Authors :: JD Studt
WA Wuillemin
A Schmidt
G Willekens
B Gerber
Lorenzo Alberio
L. Graf
Pierre Fontana
Adriana Mendez
Cédric Bovet
Michael Nagler
Source :: 65th Annual Meeting of the Society of Thrombosis and Haemostasis Research.
Publication Year :: 2021
Publisher :: Georg Thieme Verlag KG, 2021.

Subjects :: Oncology
medicine.medical_specialty
Rivaroxaban
business.industry
External validation
Diagnostic accuracy
Drug levels
chemistry.chemical_compound
chemistry
Edoxaban
Internal medicine
medicine
Apixaban
business
medicine.drug

ISSN :: 25675761
Database :: OpenAIRE
Journal :: 65th Annual Meeting of the Society of Thrombosis and Haemostasis Research
Accession number :: edsair.doi...........964ef1ae21eed2aac40c058f27897cac

Tools